Regulation of Fuels and Fuel Additives: Identification of Additional Qualifying Renewable Fuel Pathways Under the Renewable Fuel Standard Program, 13009-13010 [2012-5256]
Download as PDF
tkelley on DSK3SPTVN1PROD with RULES
Federal Register / Vol. 77, No. 43 / Monday, March 5, 2012 / Rules and Regulations
representatives are prohibited from
marketing to medical, pharmacy,
nursing and other health profession
students, including residents.
Exceptions may be permitted when
approved by, and conducted in the
presence of, the staff member providing
clinical supervision.
(4) Attendance at conferences. A
pharmaceutical company representative
may not attend a medical center
conference where information regarding
individual patients is discussed or
presented.
(5) Patient care areas. Pharmaceutical
company representatives generally may
not wait for scheduled appointments or
make presentations in patient-care
areas, but may briefly travel through
them, when necessary, to meet in a staff
member’s office. Patient-care areas
include, but are not limited to:
(i) Patient rooms and ward areas
where patients may be encountered;
(ii) Clinic examination rooms;
(iii) Nurses stations;
(iv) Intensive care units;
(v) Operating room suites;
(vi) Urgent care centers;
(vii) Emergency rooms (but not staff
offices that may be located in them); or
(viii) Ambulatory treatment centers.
(6) Distribution of materials.
Pharmaceutical company
representatives may only distribute
materials on-site at the time and
location of a scheduled appointment or
educational program. In no
circumstances may materials be left in
patient care areas.
(i) Non-compliance.
(1) General. The visiting privileges of
a pharmaceutical company
representative or multiple
representatives may be limited,
suspended, or revoked by the written
order of the Director of the VA medical
center of jurisdiction if the Director
determines the pharmaceutical
company representative(s) failed to
comply with the requirements of this
section.
(2) Notice of interim action. The
Director will notify the pharmaceutical
company representative of the
noncompliance and of the Director’s
interim action under paragraph (i)(4) of
this section. The Director will also
notify the supervisor of the
pharmaceutical company
representative(s) if there have been
multiple instances of misconduct. The
notice will offer 30 days to provide a
response; however, the interim action
will be enforced effective the date of the
notice.
(3) Final written order. At the end of
the 30-day period for a response, or after
the Director receives a timely response,
VerDate Mar<15>2010
16:55 Mar 02, 2012
Jkt 226001
the Director will issue to the
pharmaceutical company representative
and supervisor a final written order
either confirming the action taken as
indicated in the notice, or specifying
another action to be taken under
paragraph (i)(4) of this section. The
written order may also state that the
Director has determined that no further
action is required. Any final written
order issued by the Director shall
include a summary of the circumstances
of the violation, a listing of the specific
provisions of this section that the
pharmaceutical company
representative(s) violated, and the bases
for the Director’s determination
regarding the appropriate action. Notice
concerning a final written order
suspending or permanently revoking the
visiting privileges of multiple
pharmaceutical company
representatives shall include specific
notice concerning the right to review of
the Director’s order by the Under
Secretary for Health.
(4) Actions. Actions that may be
imposed under this section include
limitation, suspension, or permanent
revocation of visiting privileges at one
or more VA medical facilities. In
determining the appropriate action, the
Director shall consider the requirements
of this section, the circumstances of the
improper conduct, any prior acts of
misconduct by the same pharmaceutical
company representative, any response
submitted by the pharmaceutical
company representative or their
supervisor under paragraph (i)(2) of this
section, and any prior written orders
issued or other actions taken with
respect to similar acts of misconduct.
(5) Review. The pharmaceutical
company may request the Under
Secretary’s review within 30 days of the
date of the Director’s final written order
by submitting a written request to the
Director. The Director shall forward the
initial notice, any response, the final
written order, and the request for review
to the Under Secretary for a final VA
decision. VA will enforce the Director’s
final written order while it is under
review by the Under Secretary. The
Director will provide the individual
who made the request written notice of
the Under Secretary’s decision.
(Authority: 38 U.S.C. 501)
[FR Doc. 2012–5279 Filed 3–2–12; 8:45 am]
BILLING CODE 8320–01–P
PO 00000
Frm 00021
Fmt 4700
Sfmt 4700
13009
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 80
[EPA–HQ–OAR–2011–0542; FRL–9642–3]
RIN 2060–AR07
Regulation of Fuels and Fuel
Additives: Identification of Additional
Qualifying Renewable Fuel Pathways
Under the Renewable Fuel Standard
Program
Environmental Protection
Agency (EPA).
ACTION: Withdrawal of direct final rule.
AGENCY:
EPA published a direct final
rule on January 5, 2012 to amend the
Renewable Fuel Standard program
regulations. Because EPA received
adverse comment, we are withdrawing
the direct final rule.
DATES: Effective March 5, 2012, EPA
withdraws the direct final rule
published at 77 FR 700, on January 5,
2012.
FOR FURTHER INFORMATION CONTACT:
Vincent Camobreco, Office of
Transportation and Air Quality
(MC6401A), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460; telephone
number: (202) 564–9043; fax number:
(202) 564–1686; email address:
camobreco.vincent@epa.gov.
SUMMARY:
EPA
published a direct final rule on January
5, 2012 (77 FR 700) to amend the
Renewable Fuel Standard program
regulations. The amendments would
have expanded Table 1 of § 80.1426 to
identify additional renewable fuel
production pathways and pathway
components that could be used in
producing qualifying renewable fuel
under the Renewable Fuel Standard
program. We stated in that direct final
rule that if we received adverse
comment by February 6, 2012, that we
would publish a timely withdrawal in
the Federal Register. We subsequently
received adverse comment on several of
the changes included in the revised
Table 1 of § 80.1426. Since the
regulatory amendment in the direct final
rule was a single Table including all
changes, withdrawal based on the
adverse comments we have received
requires withdrawal of the entire
revised Table. EPA intends to address
all comments in a subsequent final
action, which will be based on the
parallel proposed rule also published on
January 5, 2012 (77 FR 462).
As stated in the direct final rule and
the parallel proposed rule, we will not
SUPPLEMENTARY INFORMATION:
E:\FR\FM\05MRR1.SGM
05MRR1
13010
Federal Register / Vol. 77, No. 43 / Monday, March 5, 2012 / Rules and Regulations
institute a second comment period on
this action.
Dated: February 27, 2012.
Lisa P. Jackson,
Administrator.
Accordingly, the regulatory
amendments published on January 5,
2012 (77 FR 700) are withdrawn as of
March 5, 2012.
[FR Doc. 2012–5256 Filed 3–2–12; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
44 CFR Part 64
[Docket ID FEMA–2012–0003; Internal
Agency Docket No. FEMA–8221]
Suspension of Community Eligibility
Federal Emergency
Management Agency, DHS.
ACTION: Final rule.
AGENCY:
This rule identifies
communities where the sale of flood
insurance has been authorized under
the National Flood Insurance Program
(NFIP) that are scheduled for
suspension on the effective dates listed
within this rule because of
noncompliance with the floodplain
management requirements of the
program. If the Federal Emergency
Management Agency (FEMA) receives
documentation that the community has
adopted the required floodplain
management measures prior to the
effective suspension date given in this
rule, the suspension will not occur and
a notice of this will be provided by
publication in the Federal Register on a
subsequent date.
DATES: Effective Dates: The effective
date of each community’s scheduled
suspension is the third date (‘‘Susp.’’)
listed in the third column of the
following tables.
FOR FURTHER INFORMATION CONTACT: If
you want to determine whether a
particular community was suspended
on the suspension date or for further
information, contact David Stearrett,
Federal Insurance and Mitigation
Administration, Federal Emergency
Management Agency, 500 C Street SW.,
Washington, DC 20472, (202) 646–2953.
SUPPLEMENTARY INFORMATION: The NFIP
enables property owners to purchase
Federal flood insurance that is not
tkelley on DSK3SPTVN1PROD with RULES
SUMMARY:
VerDate Mar<15>2010
16:55 Mar 02, 2012
Jkt 226001
otherwise generally available from
private insurers. In return, communities
agree to adopt and administer local
floodplain management measures aimed
at protecting lives and new construction
from future flooding. Section 1315 of
the National Flood Insurance Act of
1968, as amended, 42 U.S.C. 4022,
prohibits the sale of NFIP flood
insurance unless an appropriate public
body adopts adequate floodplain
management measures with effective
enforcement measures. The
communities listed in this document no
longer meet that statutory requirement
for compliance with program
regulations, 44 CFR part 59.
Accordingly, the communities will be
suspended on the effective date in the
third column. As of that date, flood
insurance will no longer be available in
the community. We recognize that some
of these communities may adopt and
submit the required documentation of
legally enforceable floodplain
management measures after this rule is
published but prior to the actual
suspension date. These communities
will not be suspended and will continue
to be eligible for the sale of NFIP flood
insurance. A notice withdrawing the
suspension of such communities will be
published in the Federal Register.
In addition, FEMA publishes a Flood
Insurance Rate Map (FIRM) that
identifies the Special Flood Hazard
Areas (SFHAs) in these communities.
The date of the FIRM, if one has been
published, is indicated in the fourth
column of the table. No direct Federal
financial assistance (except assistance
pursuant to the Robert T. Stafford
Disaster Relief and Emergency
Assistance Act not in connection with a
flood) may be provided for construction
or acquisition of buildings in identified
SFHAs for communities not
participating in the NFIP and identified
for more than a year on FEMA’s initial
FIRM for the community as having
flood-prone areas (section 202(a) of the
Flood Disaster Protection Act of 1973,
42 U.S.C. 4106(a), as amended). This
prohibition against certain types of
Federal assistance becomes effective for
the communities listed on the date
shown in the last column. The
Administrator finds that notice and
public comment procedures under 5
U.S.C. 553(b), are impracticable and
unnecessary because communities listed
in this final rule have been adequately
notified.
Each community receives 6-month,
90-day, and 30-day notification letters
addressed to the Chief Executive Officer
stating that the community will be
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
suspended unless the required
floodplain management measures are
met prior to the effective suspension
date. Since these notifications were
made, this final rule may take effect
within less than 30 days.
National Environmental Policy Act.
This rule is categorically excluded from
the requirements of 44 CFR part 10,
Environmental Considerations. No
environmental impact assessment has
been prepared.
Regulatory Flexibility Act. The
Administrator has determined that this
rule is exempt from the requirements of
the Regulatory Flexibility Act because
the National Flood Insurance Act of
1968, as amended, Section 1315, 42
U.S.C. 4022, prohibits flood insurance
coverage unless an appropriate public
body adopts adequate floodplain
management measures with effective
enforcement measures. The
communities listed no longer comply
with the statutory requirements, and
after the effective date, flood insurance
will no longer be available in the
communities unless remedial action
takes place.
Regulatory Classification. This final
rule is not a significant regulatory action
under the criteria of section 3(f) of
Executive Order 12866 of September 30,
1993, Regulatory Planning and Review,
58 FR 51735.
Executive Order 13132, Federalism.
This rule involves no policies that have
federalism implications under Executive
Order 13132.
Executive Order 12988, Civil Justice
Reform. This rule meets the applicable
standards of Executive Order 12988.
Paperwork Reduction Act. This rule
does not involve any collection of
information for purposes of the
Paperwork Reduction Act, 44 U.S.C.
3501 et seq.
List of Subjects in 44 CFR Part 64
Flood insurance, Floodplains.
Accordingly, 44 CFR part 64 is
amended as follows:
PART 64—[AMENDED]
1. The authority citation for part 64
continues to read as follows:
■
Authority: 42 U.S.C. 4001 et seq.;
Reorganization Plan No. 3 of 1978, 3 CFR,
1978 Comp.; p. 329; E.O. 12127, 44 FR 19367,
3 CFR, 1979 Comp.; p. 376.
§ 64.6
[Amended]
2. The tables published under the
authority of § 64.6 are amended as
follows:
■
E:\FR\FM\05MRR1.SGM
05MRR1
Agencies
[Federal Register Volume 77, Number 43 (Monday, March 5, 2012)]
[Rules and Regulations]
[Pages 13009-13010]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5256]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 80
[EPA-HQ-OAR-2011-0542; FRL-9642-3]
RIN 2060-AR07
Regulation of Fuels and Fuel Additives: Identification of
Additional Qualifying Renewable Fuel Pathways Under the Renewable Fuel
Standard Program
AGENCY: Environmental Protection Agency (EPA).
ACTION: Withdrawal of direct final rule.
-----------------------------------------------------------------------
SUMMARY: EPA published a direct final rule on January 5, 2012 to amend
the Renewable Fuel Standard program regulations. Because EPA received
adverse comment, we are withdrawing the direct final rule.
DATES: Effective March 5, 2012, EPA withdraws the direct final rule
published at 77 FR 700, on January 5, 2012.
FOR FURTHER INFORMATION CONTACT: Vincent Camobreco, Office of
Transportation and Air Quality (MC6401A), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460; telephone
number: (202) 564-9043; fax number: (202) 564-1686; email address:
camobreco.vincent@epa.gov.
SUPPLEMENTARY INFORMATION: EPA published a direct final rule on January
5, 2012 (77 FR 700) to amend the Renewable Fuel Standard program
regulations. The amendments would have expanded Table 1 of Sec.
80.1426 to identify additional renewable fuel production pathways and
pathway components that could be used in producing qualifying renewable
fuel under the Renewable Fuel Standard program. We stated in that
direct final rule that if we received adverse comment by February 6,
2012, that we would publish a timely withdrawal in the Federal
Register. We subsequently received adverse comment on several of the
changes included in the revised Table 1 of Sec. 80.1426. Since the
regulatory amendment in the direct final rule was a single Table
including all changes, withdrawal based on the adverse comments we have
received requires withdrawal of the entire revised Table. EPA intends
to address all comments in a subsequent final action, which will be
based on the parallel proposed rule also published on January 5, 2012
(77 FR 462).
As stated in the direct final rule and the parallel proposed rule,
we will not
[[Page 13010]]
institute a second comment period on this action.
Dated: February 27, 2012.
Lisa P. Jackson,
Administrator.
Accordingly, the regulatory amendments published on January 5, 2012
(77 FR 700) are withdrawn as of March 5, 2012.
[FR Doc. 2012-5256 Filed 3-2-12; 8:45 am]
BILLING CODE 6560-50-P